Type III chronic prostatitis
Conditions
Interventions
Treatment group:Qianlie Xiaozhuo Formula, composition: Anemarrhena 10g, Phellodendron 12g, Chuanxiong 12g, Angelica Dahurica 10g, Raw Astragalus 20g, Corydalis 10g, Cyperus 10g, Dryopteris 15g, Diosco
Control group:Tamsulosin hydrochloride sustained-release capsules, 0.2 mg qn, for 4 consecutive weeks.
Sponsors
Shunyi Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
Male
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 20 to 50 years old; 2. Not taking medications such as Qianlie Antong Capsules, Qianlie Tai Capsules, Qianlie Xin Capsules, etc. to treat the disease within one week before treatment; 3. Evaluation of indicators related to chronic prostatitis: PHQ-9 depression score >= 5 points, GAD-7 anxiety score >= 5 points, IIEF-5 score <= 21 points. 4. Meets the diagnostic criteria for type III CP set by the National Institutes of Health (NIH) and the Chinese Guidelines for Diagnosis and Treatment of Urological and Andrological Diseases (2019 edition); 5. Complies with the syndrome criteria for damp heat and stasis syndrome in the Clinical Research Guidelines for the Treatment of Chronic Prostatitis with Traditional Chinese Medicine; 6. The process of signing informed consent, voluntarily participating in the trial, and obtaining informed consent should comply with GCP regulations.
Exclusion criteria
Exclusion criteria: 1. Recurrent lower urinary tract infections, or suffering from testicular and epididymitis, varicocele, severe urethral stricture, etc; 2. Combined with basic diseases such as benign prostatic hyperplasia, prostate tumors, severe cardiovascular and cerebrovascular diseases, respiratory system diseases, liver and kidney dysfunction, etc; 3. Merge other severe systemic infections; 4. Patients who cannot obtain fully informed consent due to intellectual or behavioral impairments; 5. Patients with a history of alcohol and drug abuse, suspected or confirmed; 6. Patients who are prone to loss to follow-up, according to the researchers' judgment, may have a lower likelihood of inclusion or be complicated by other lesions; 7. Patients who have experienced dizziness with needles or blood in the past, or have a slow coagulation process after blood drawing, or are sensitive to pain and unable to complete blood drawing. 8. Patients who have ever had allergic reactions to oral Chinese medicine or traditional Chinese patent medicines and simple preparations, such as skin rash, itching, redness, dyspnea, nausea, vomiting, diarrhea and other symptoms.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIH-CPSI Points; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Syndrome Score;PHQ-9 Depression Score;GAD-7 Anxiety Score;IIEF-5 Score;Urine Routine;Prostate Massage Fluid Routine; | — |
Countries
China
Contacts
Public ContactSheng Deng
Shunyi Hospital of Traditional Chinese Medicine
Outcome results
None listed